Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$22.1

Avg closing price
Price range

5 Jeremy Grantham Supernus Pharmaceuticals Trades

The first Supernus Pharmaceuticals trade was made in Q1 2017. Since then Jeremy Grantham bought shares two more times and sold shares on two occasions. The investor sold all their shares in Q1 2021 and doesn't own any shares in Supernus Pharmaceuticals anymore.

Avg closing price
Price range
Sold -21.9 Thousand shares Q1 2021
Avg closing price $27.97
Price range $24.15 - $31.45
Increased shares by 119.0% (+11.9 Thousand shares) Q4 2020
Avg closing price $21.52
Price range $17.70 - $25.81
New holding (+10 Thousand shares) Q3 2020
Avg closing price $22.70
Price range $20.20 - $25.05
Sold -8.2 Thousand shares Q4 2017
Avg closing price $39.52
Price range $36.40 - $42.60
New holding (+8.2 Thousand shares) Q1 2017
Avg closing price $26.80
Price range $23.45 - $31.30

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!